UBS O’Connor, a multi-strategy hedge fund manager within UBS Asset Management, has hired Jason Bonadio MD, Robert Sweeney MD, and Adam Sandler MD to manage a relative value equity strategy focusing on the healthcare therapeutics industry.

Bonadio joins as a Healthcare Portfolio Manager. Prior to this role, he co-founded Alera Partners, a long/short equity healthcare fund investing in the biotechnology, medical technology, pharmaceutical and life science tools sectors. Bonadio was also a founding partner and a co-portfolio manager of the FrontPoint Healthcare Funds.
 
Sweeney joins as a Healthcare Research Analyst. Sweeney is a board-eligible surgeon that joined Alera Partners in 2021. Previously, he worked as a sell-side equity research analyst at HC Wainwright, with coverage across therapeutic areas and medical devices. He is currently a PhD candidate in Immunology at the Icahn School of Medicine at Mount Sinai in NYC.
 
Sandler joins as a Healthcare Research Analyst. Sandler is currently the chief resident in the Department of Occupational Medicine at Mount Sinai. He joined Alera Partners in 2021 and was previously a healthcare analyst at Guidepoint Global. After graduating, cum laude from Harvard University in 2004, he received awards for his work from the New York Academy of Medicine, Crohn’s and Colitis Foundation of America, and Adenosine Therapeutics at Mount Sinai School of Medicine.